drug · small molecule
empagliflozin
Phase 3updated 3mo agoby Boehringer Ingelheim International GmbH🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 37 investigational indications.
targets
Sodium/glucose cotransporter 2
all catalysts(0)
nothing on the calendar yet
Trials studying empagliflozin
- —Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure
- phase3A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- phase4Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
- phase2A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
- phase2A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- N/ACLINICAL STUDY TO DETERMINE BIOEQUIVALENCE BETWEEN TWO ORAL MEDICATIONS OF EMPAGLIFLOZIN/METFORMIN IN 5 mg / 850 mg TABLETS UNDER FED CONDITIONS.
- phase3A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- phase3EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
News(1)
- Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launchA strong performance from Mounjaro overseas boosted Lilly’s results, and the company raised its guidance for the year for both profit and revenue.biopharma_dive · 3mo ago
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that